A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

Filer Snapshot

Apimeds Pharmaceuticals US, Inc. SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0001894525.

Entity Type

Company

Total Filings

117

Latest Filing

15 May 2026

Industry

Pharmaceutical Preparations

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

Use the filings table to verify the newest submission, form type, and report period.
Open the deeper context page only when this filer actually has insider or ownership signal.

Go to latest filings table Open insider trading context

Source: SEC filing NT 10-Q

NT 10-Q filed on 15 May 2026 for CIK 0001894525.

View Source Filing

Symbol: APUS on NYSE
Industry: Pharmaceutical Preparations (Office Of Life Sciences)
Business address: 100 Matawan Rd, Suite 325, Matawan, NJ, 07747
State of incorporation: DE
Fiscal year end: 31 December

Key facts

Apimeds Pharmaceuticals US, Inc. is an SEC filer tracked under CIK 0001894525.
117 filings are listed on this profile.
Common form coverage includes NT 10-Q, SCHEDULE 13D/A, 8-K and more.

Change

Latest filing: NT 10-Q filed on 15 May 2026.
Report period: 31 Mar 2026.

Research use

You can quote filing dates and form types directly from the SEC record on this page.
Use this profile before deeper ownership or insider analysis to confirm filing history context.

Evidence

Source: SEC filing NT 10-Q

NT 10-Q filed on 15 May 2026 for CIK 0001894525.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed NT 10-Q can change the filing history, ownership context, or next research path for Apimeds Pharmaceuticals US, Inc..

Latest source-backed update: NT 10-Q filed 15 May 2026
Why come back: Revisit after a new SEC filing appears to compare the updated record with prior filings.

Latest filing on record: NT 10-Q filed 15 May 2026.
Save this filer if you want a stable place to return after the next filing cycle.
Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Jump to save and follow actions Open latest filings table

Latest update

What changed recently for Apimeds Pharmaceuticals US, Inc.

New fact period available

Latest financial period: Q4 2025. Open the source-backed page to inspect the fresh filing or facts context.

Update date

04 May 2026

Page type

Company facts

Latest period

Q4 2025

SEC-backed company facts were refreshed from filings filed on 04 May 2026.

Open company facts Browse recent public updates

Benchmark Context

Benchmark context for this company

Apimeds Pharmaceuticals US, Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest financial period: Q4 2025. That gives you a fresh baseline before you compare this company with peers.

Latest company facts filing date: 04 May 2026.
Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Open company facts Browse metric rankings

Company intelligence

Apimeds Pharmaceuticals US, Inc.: filings, ownership, insiders

CIK 0001894525. Open the active data lane, then verify the SEC filing behind the row.

Create free account to watch this company Open ownership signals

Active modules

3/5

Available company intelligence paths on this page.

Filings

117

SEC submissions provide the evidence trail.

Ownership context

1/3

Insider, large-stake, and institutional ownership lanes.

Return loop

Watch

Return when a new SEC-backed change lands.

Research checks

Latest filing

NT 10-Q filed 15 May 2026

Ownership lanes

1/3 active

CIK

0001894525

Next review

watch new filing, insider, 13D/G, or 13F change

SEC-verifiable company research path

Keep the next click tied to one changing object: a CIK, filing, insider, Schedule 13D/G holder, Form 13F manager, or security.

Open latest insider signals Open large-stake radar

SEC filings

Available

Latest company filings

Start with the filing timeline to verify the newest source document and report period.

Open filings table

Company facts

Available

Financial context

Use XBRL facts when ownership activity needs revenue, earnings, debt, or cash-flow context.

Open company facts

Forms 3/4/5

Available

Insider activity

Check whether directors, officers, or 10% owners are buying, selling, or filing fresh ownership changes.

Open insider activity

Schedule 13D/G

Explore

Large-stake holders

Review beneficial ownership filings for activist-style or passive large holder changes around this issuer.

Browse large-stake radar

Form 13F

Explore

Institutional holders

Compare manager filings and smart-money context when company-level ownership needs broader holders.

Browse smart-money dashboard

SEC-verifiable company hub

Filings first, then ownership signals, insider context, and fundamentals.

Create free account to watch this company

Watchlist return triggers

Watch Apimeds Pharmaceuticals US, Inc. when any filing-backed ownership signal appears, then jump back into the exact SEC evidence path.

new company filing insider Form 4 13D/G holder change 13F holder update

Filer Overview

Apimeds Pharmaceuticals US, Inc. has filed 117 SEC EDGAR filings since 29 Jan 2024. Common forms include NT 10-Q, SCHEDULE 13D/A, 8-K, 10-K and more.

Apimeds Pharmaceuticals US, Inc. SEC filings Apimeds Pharmaceuticals US, Inc. insider transactions Apimeds Pharmaceuticals US, Inc. company facts

Latest Filings

Recent SEC filings for Apimeds Pharmaceuticals US, Inc. with direct links to document and filing folders.

NT 10-Q File 001-42545

NOTIFICATION OF LATE FILING

Filing date: 15 May 2026
Reporting date: 31 Mar 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13D/A File 005-95043

SCHEDULE 13D/A filing

Filing date: 07 May 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 05 May 2026
Reporting date: 05 May 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-42545

ANNUAL REPORT

Filing date: 04 May 2026
Reporting date: 31 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 04 May 2026
Reporting date: 24 Apr 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

FORM 8-K

Filing date: 22 Apr 2026
Reporting date: 17 Apr 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 16 Apr 2026
Reporting date: 15 Apr 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

425 File 001-42545

AMENDMENT NO. 1 TO FORM 8-K

Filing date: 09 Apr 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K/A File 001-42545

AMENDMENT NO. 1 TO FORM 8-K

Filing date: 09 Apr 2026
Reporting date: 20 Mar 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

NT 10-K File 001-42545

NOTIFICATION OF LATE FILING

Filing date: 31 Mar 2026
Reporting date: 31 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13D/A File 005-95043

SCHEDULE 13D/A filing

Filing date: 30 Mar 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 26 Mar 2026
Reporting date: 20 Mar 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 25 Mar 2026
Reporting date: 20 Mar 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SCHEDULE 13D/A File 005-95043

SCHEDULE 13D/A filing

Filing date: 20 Mar 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 16 Mar 2026
Reporting date: 16 Mar 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEFM14C File 001-42545

INFORMATION STATEMENT

Filing date: 27 Feb 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

425 File 001-42545

AMENDMENT NO. 2 TO FORM 8-K

Filing date: 17 Feb 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K/A File 001-42545

AMENDMENT NO. 2 TO FORM 8-K

Filing date: 17 Feb 2026
Reporting date: 01 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SCHEDULE 13G File 005-95043

SCHEDULE 13G filing

Filing date: 11 Feb 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13D/A File 005-95043

SCHEDULE 13D/A filing

Filing date: 26 Jan 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

PREM14C File 001-42545

INFORMATION STATEMENT

Filing date: 16 Jan 2026
Reporting date: 16 Jan 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 02 Jan 2026
Reporting date: 30 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 10 Dec 2025
Reporting date: 05 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K/A File 001-42545

AMENDMENT NO. 1 TO FORM 8-K

Filing date: 10 Dec 2025
Reporting date: 01 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

425 File 001-42545

CURRENT REPORT

Filing date: 02 Dec 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 02 Dec 2025
Reporting date: 01 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4/A

PRIMARY DOCUMENT

Filing date: 21 Nov 2025
Reporting date: 12 May 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 18 Nov 2025
Reporting date: 13 Nov 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 13 Nov 2025
Reporting date: 11 Nov 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 13 Nov 2025
Reporting date: 11 Nov 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 13 Nov 2025
Reporting date: 11 Nov 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 13 Nov 2025
Reporting date: 11 Nov 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 13 Nov 2025
Reporting date: 11 Nov 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-42545

QUARTERLY REPORT

Filing date: 12 Nov 2025
Reporting date: 30 Sep 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 24 Oct 2025
Reporting date: 15 Oct 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 21 Oct 2025
Reporting date: 15 Oct 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 17 Oct 2025
Reporting date: 15 Oct 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 17 Oct 2025
Reporting date: 15 Oct 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 17 Oct 2025
Reporting date: 15 Oct 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 17 Oct 2025
Reporting date: 15 Oct 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 17 Oct 2025
Reporting date: 15 Oct 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 16 Oct 2025
Reporting date: 15 Oct 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-42545

QUARTERLY REPORT

Filing date: 19 Aug 2025
Reporting date: 30 Jun 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

NT 10-Q File 001-42545

NOTIFICATION OF LATE FILING

Filing date: 14 Aug 2025
Reporting date: 30 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 16 Jul 2025
Reporting date: 15 Jul 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4/A

PRIMARY DOCUMENT

Filing date: 11 Jun 2025
Reporting date: 12 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

3/A

PRIMARY DOCUMENT

Filing date: 11 Jun 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 05 Jun 2025
Reporting date: 30 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

S-8 File 333-287564

REGISTRATION STATEMENT

Filing date: 23 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-42545

QUARTERLY REPORT

Filing date: 20 May 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SCHEDULE 13D File 005-95043

SCHEDULE 13D filing

Filing date: 19 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 15 May 2025
Reporting date: 13 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

NT 10-Q File 001-42545

NOTIFICATION OF LATE FILING

Filing date: 15 May 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 14 May 2025
Reporting date: 12 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 14 May 2025
Reporting date: 12 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

3/A

PRIMARY DOCUMENT

Filing date: 14 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 12 May 2025
Reporting date: 08 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

424B4 File 333-282324

PROSPECTUS

Filing date: 09 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 08 May 2025
Reporting date: 04 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-282324

EFFECT filing

Filing date: 05 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 05 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 05 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD File 001-42545

UPLOAD filing

Filing date: 05 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

POS AM File 333-282324

POST-EFFECTIVE AMENDMENT

Filing date: 02 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K/A File 001-42545

AMENDMENT NO. 1 TO FORM 10-K

Filing date: 02 May 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 01 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 01 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

POS AM File 333-282324

POST-EFFECTIVE AMENDMENT

Filing date: 01 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

UPLOAD File 001-42545

UPLOAD filing

Filing date: 01 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD File 333-282324

UPLOAD filing

Filing date: 30 Apr 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

POS AM File 333-282324

POST-EFFECTIVE AMENDMENT

Filing date: 17 Apr 2025
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-42545

ANNUAL REPORT

Filing date: 15 Apr 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 15 Apr 2025
Reporting date: 11 Apr 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

NT 10-K File 001-42545

NOTIFICATION OF LATE FILING

Filing date: 31 Mar 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

CERT File 001-42545

NYSE AMERICAN CERTIFICATION

Filing date: 04 Mar 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-A12B File 001-42545

FOR REGISTRATION OF CERTAIN CLASSES

Filing date: 03 Mar 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-282324

EFFECT filing

Filing date: 11 Feb 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

FWP File 333-282324

FREE WRITING PROSPECTUS

Filing date: 10 Feb 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 10 Feb 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1/A File 333-282324

REGISTRATION STATEMENT

Filing date: 10 Feb 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD File 377-07074

UPLOAD filing

Filing date: 07 Feb 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 07 Feb 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 07 Feb 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1/A File 333-282324

REGISTRATION STATEMENT

Filing date: 06 Feb 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1/A File 333-282324

REGISTRATION STATEMENT

Filing date: 29 Jan 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1/A File 333-282324

REGISTRATION STATEMENT

Filing date: 10 Jan 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1/A File 333-282324

REGISTRATION STATEMENT

Filing date: 20 Dec 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 19 Dec 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD File 377-07074

UPLOAD filing

Filing date: 16 Dec 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1/A File 333-282324

REGISTRATION STATEMENT

Filing date: 09 Dec 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1/A File 333-282324

REGISTRATION STATEMENT

Filing date: 08 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1 File 333-282324

REGISTRATION STATEMENT

Filing date: 25 Sep 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DRS/A File 377-07074

DRS/A filing

Filing date: 05 Aug 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DRSLTR

DRSLTR filing

Filing date: 02 Aug 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DRS/A File 377-07074

DRS/A filing

Filing date: 17 Jun 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DRSLTR

DRSLTR filing

Filing date: 14 Jun 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD File 377-07074

UPLOAD filing

Filing date: 23 May 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DRSLTR

DRSLTR filing

Filing date: 13 May 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DRS/A File 377-07074

DRS/A filing

Filing date: 13 May 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD File 377-07074

UPLOAD filing

Filing date: 26 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DRS File 377-07074

DRS filing

Filing date: 29 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

About this filer

Apimeds Pharmaceuticals US, Inc. files with the SEC under CIK 0001894525. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

FAQ

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.